Urinary proteome profiling for stratifying patients with familial Parkinson’s disease

EMBO Molecular Medicine

Roy N Alcalay¹  Matthew Surface¹  Sebastian Virreira Winter²  Ozge Karayel²  Maximilian T Strauss²  Matthias Mann³  Kalpana Merchant⁴  Shalini Padmanabhan⁵ 

[1] Department of Neurology, Columbia University, New York, NY, USA;Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany;Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany;Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;Northwestern University Feinberg School of Medicine, Chicago, IL, USA;The Michael J. Fox Foundation for Parkinson’s Research, New York, NY, USA;

关键词: biomarker;    DIA;    mass spectrometry;    Parkinson’s disease;    urinary proteome;   

DOI  :  10.15252/emmm.202013257

来源: Wiley

【 授权许可】

CC BY